R Mössner1, D Wilsmann-Theis2, V Oji3, P Gkogkolou3, S Löhr4, P Schulz5, A Körber6, J C Prinz7, R Renner8, K Schäkel9, L Vogelsang9, K-P Peters10, S Philipp11, K Reich12, H Ständer13, A Jacobi14, A Weyergraf5, K Kingo15, S Kõks16, S Gerdes17, K Steinz17, T Schill2, K G Griewank6, M Müller18, S Frey19, L Ebertsch4, S Uebe4, M Sticherling8, H Sticht20, U Hüffmeier4. 1. Department of Dermatology, Georg-August-University Göttingen, Göttingen, Germany. 2. Department of Dermatology and Allergy, University Bonn, Bonn, Germany. 3. Department of Dermatology, University Münster, Münster, Germany. 4. Institute of Human Genetics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany. 5. Department of Dermatology, Fachklinik Bad Bentheim, Bad Bentheim, Germany. 6. Department of Dermatology, University of Essen, Essen, Germany. 7. Department of Dermatology and Allergology, Ludwig-Maximilian University Munich, Munich, Germany. 8. Department of Dermatology, University Hospital Erlangen, Erlangen, Germany. 9. Department of Dermatology, University Hospital Heidelberg, Heidelberg, Germany. 10. Department of Dermatology and Allergology, Hospital Bayreuth, Bayreuth, Germany. 11. Department of Dermatology and Allergy, Charité Universitätsmedizin Berlin, Berlin, Germany. 12. Dermatologikum Hamburg, Hamburg, Germany. 13. Department of Dermatology, Klinikum Dortmund, Dortmund, Germany. 14. Institute for Health Services Research in Dermatology and Nursing, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. 15. Department of Dermatology, Dermatology Clinic, University of Tartu, Tartu, Estonia. 16. Department of Pathophysiology, University of Tartu, Tartu, Estonia. 17. Department of Dermatology, University of Kiel, Kiel, Germany. 18. Institute of Occcupational, Social and Environmental Medicine, Georg-August-University Göttingen, Göttingen, Germany. 19. Department of Internal Medicine 3 - Rheumatology and Immunology, Universitätsklinikum Erlangen, Erlangen, Germany. 20. Bioinformatics, Institute of Biochemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Abstract
BACKGROUND: Rare variants in the genes IL36RN, CARD14 and AP1S3 have been identified to cause or contribute to pustular skin diseases, primarily generalized pustular psoriasis (GPP). OBJECTIVES: To better understand the disease relevance of these genes, we screened our cohorts of patients with pustular skin diseases [primarily GPP and palmoplantar pustular psoriasis (PPP)] for coding changes in these three genes. Carriers of single heterozygous IL36RN mutations were screened for a second mutation in IL36RN. METHODS: Coding exons of IL36RN, CARD14 and AP1S3 were sequenced in 67 patients - 61 with GPP, two with acute generalized exanthematous pustulosis and four with acrodermatitis continua of Hallopeau. We screened IL36RN and AP1S3 for intragenic copy-number variants and 258 patients with PPP for coding changes in AP1S3. Eleven heterozygous IL36RN mutations carriers were analysed for a second noncoding IL36RN mutation. Genotype-phenotype correlations in carriers/noncarriers of IL36RN mutations were assessed within the GPP cohort. RESULTS: The majority of patients (GPP, 64%) did not carry rare variants in any of the three genes. Biallelic and monoallelic IL36RN mutations were identified in 15 and five patients with GPP, respectively. Noncoding rare IL36RN variants were not identified in heterozygous carriers. The only significant genotype-phenotype correlation observed for IL36RN mutation carriers was early age at disease onset. Additional rare CARD14 or AP1S3 variants were identified in 15% of IL36RN mutation carriers. CONCLUSIONS: The identification of IL36RN mutation carriers harbouring additional rare variants in CARD14 or AP1S3 indicates a more complex mode of inheritance of pustular psoriasis. Our results suggest that, in heterozygous IL36RN mutation carriers, there are additional disease-causing genetic factors outside IL36RN.
BACKGROUND: Rare variants in the genes IL36RN, CARD14 and AP1S3 have been identified to cause or contribute to pustular skin diseases, primarily generalized pustular psoriasis (GPP). OBJECTIVES: To better understand the disease relevance of these genes, we screened our cohorts of patients with pustular skin diseases [primarily GPP and palmoplantar pustular psoriasis (PPP)] for coding changes in these three genes. Carriers of single heterozygous IL36RN mutations were screened for a second mutation in IL36RN. METHODS: Coding exons of IL36RN, CARD14 and AP1S3 were sequenced in 67 patients - 61 with GPP, two with acute generalized exanthematous pustulosis and four with acrodermatitis continua of Hallopeau. We screened IL36RN and AP1S3 for intragenic copy-number variants and 258 patients with PPP for coding changes in AP1S3. Eleven heterozygous IL36RN mutations carriers were analysed for a second noncoding IL36RN mutation. Genotype-phenotype correlations in carriers/noncarriers of IL36RN mutations were assessed within the GPP cohort. RESULTS: The majority of patients (GPP, 64%) did not carry rare variants in any of the three genes. Biallelic and monoallelic IL36RN mutations were identified in 15 and five patients with GPP, respectively. Noncoding rare IL36RN variants were not identified in heterozygous carriers. The only significant genotype-phenotype correlation observed for IL36RN mutation carriers was early age at disease onset. Additional rare CARD14 or AP1S3 variants were identified in 15% of IL36RN mutation carriers. CONCLUSIONS: The identification of IL36RN mutation carriers harbouring additional rare variants in CARD14 or AP1S3 indicates a more complex mode of inheritance of pustular psoriasis. Our results suggest that, in heterozygous IL36RN mutation carriers, there are additional disease-causing genetic factors outside IL36RN.
Authors: Di Yan; Johann E Gudjonsson; Stephanie Le; Emanual Maverakis; Olesya Plazyo; Christopher Ritchlin; Jose U Scher; Roopesh Singh; Nicole L Ward; Stacie Bell; Wilson Liao Journal: J Invest Dermatol Date: 2021-07-22 Impact factor: 8.551
Authors: Ranjitha Uppala; Lam C Tsoi; Paul W Harms; Bo Wang; Allison C Billi; Emanual Maverakis; J Michelle Kahlenberg; Nicole L Ward; Johann E Gudjonsson Journal: Cell Mol Immunol Date: 2020-08-19 Impact factor: 11.530
Authors: Sophie Twelves; Alshimaa Mostafa; Nick Dand; Elias Burri; Katalin Farkas; Rosemary Wilson; Hywel L Cooper; Alan D Irvine; Hazel H Oon; Külli Kingo; Sulev Köks; Ulrich Mrowietz; Luis Puig; Nick Reynolds; Eugene Sern-Ting Tan; Adrian Tanew; Kaspar Torz; Hannes Trattner; Mark Valentine; Shyamal Wahie; Richard B Warren; Andrew Wright; Zsuzsa Bata-Csörgő; Marta Szell; Christopher E M Griffiths; A David Burden; Siew-Eng Choon; Catherine H Smith; Jonathan N Barker; Alexander A Navarini; Francesca Capon Journal: J Allergy Clin Immunol Date: 2018-07-21 Impact factor: 10.793